EXPERIMENTAL STUDY OF THE EFFECT OF NEW DICARBOXYLIC ACID DERIVATIVES WITH ANTI-INFLAMMATORY ACTIVITY ON THE IMMUNE SYSTEM
Bulletin of medicine, psychology and pharmacy · 2025
DOI: 10.20998/bmpp.2024.02.04 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bulletin of medicine, psychology and pharmacy, 2025. Verfasst von Larysa Iakovlieva und 1 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
Given the wide spread of inflammatory diseases, adequate treatment of this pathological process is of great social importance. The second half of the last century was characterised by an intensive search for new effective and safe Nonsteroidal anti-inflammatory drug (NSAIDs). Selective COX-2 inhibitors such as meloxicam and celecoxib were developed, but they have serious shortcomings. Therefore, even today, the search for new NSAIDs that can affect severe chronic inflammatory diseases is relevant. The purpose was an experimental study of the immunotropic properties of new dicarboxylic acid derivatives with the following names: succizol, oxaglucamine, glucamine, and substance 15b. Materials and methods. The comparators were highly effective non-selective NSAIDs: indomethacin and piroxicam. The effect of pharmacological substances on humoral and cellular immunity and phagocytosis was studied.
Results
Dicarboxylic acid preparations are inferior to indomethacin and piroxicam in their ability to suppress the humoral link of immunity and more clearly reduced the cellular immune response. All drugs, with the exception of glucamine, significantly reduced the GST Response Index and did not cause significant changes in the results of GVHD. At the same time, a clear decrease in phagocytosis activity was observed, with the exception of glucamine, which showed a tendency to an immunostimulating effect.
Conclusions
Despite the differences in the immunotropic effects of all the studied drugs, there is a possible direct or indirect stimulating effect on T-suppressors, which normally, with the cooperation of immunocompetent cells, suppress the activity of T-helpers, which is an important point for limiting the pathogenesis of autoimmune diseases and provides prospects for further studies of dicarboxylic acid derivatives.
Zitieren
APA
Iakovlieva, L., & Hrubnyk, I. (2025). EXPERIMENTAL STUDY OF THE EFFECT OF NEW DICARBOXYLIC ACID DERIVATIVES WITH ANTI-INFLAMMATORY ACTIVITY ON THE IMMUNE SYSTEM. Bulletin of medicine, psychology and pharmacy. https://doi.org/10.20998/bmpp.2024.02.04
Vancouver
Iakovlieva L, Hrubnyk I. EXPERIMENTAL STUDY OF THE EFFECT OF NEW DICARBOXYLIC ACID DERIVATIVES WITH ANTI-INFLAMMATORY ACTIVITY ON THE IMMUNE SYSTEM. Bulletin of medicine, psychology and pharmacy. 2025. doi:10.20998/bmpp.2024.02.04
BibTeX
@article{Iakovlieva2025,
author = {Iakovlieva, Larysa and Hrubnyk, Ihor},
title = {EXPERIMENTAL STUDY OF THE EFFECT OF NEW DICARBOXYLIC ACID DERIVATIVES WITH ANTI-INFLAMMATORY ACTIVITY ON THE IMMUNE SYSTEM},
journal = {Bulletin of medicine, psychology and pharmacy},
year = {2025},
doi = {10.20998/bmpp.2024.02.04}
}
EUVIMED